Standard Chartered CEO Apologizes for Lower Value Human Capital Remark Burberry Shares Climb on Report of Potential Moncler Takeover Interest EU Plastic Bottle Cap Regulation A Case Study in the Value of Regulation AI Wealth Must Serve Public Good South Koreas Deputy PM Warns Amid Samsung Labor Unrest Forgotten 1989 Gold Heap in Nevada Emerges as Potential NearTerm Antimony Source Prediction Market Investment Surge Continues Despite Regulatory Uncertainty Earnings Calls Reveal Firm Commitment KMB Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher USPH Q1 2026 Earnings EPS Misses Estimates by Over 17 Stock Declines NEWTG Q1 2026 Earnings EPS Misses Estimates Company Navigates Shifting Interest Rate Environment GROV Q1 2026 Earnings Strong EPS Beat Signals Operational Progress HSY Q1 2026 Earnings EPS Surges Past Estimates Shares Rise on Confectionery Strength SVCO Q1 2026 Earnings EPS Surprises to the Upside Despite Narrower Loss Stock Rises Mesabi Trust MSB Edges Higher Holds Above Key Support Level Scholar Rock SRRK Surges Over 6 Key Levels to Watch After the Jump Creative Medical Technology Holdings CELZ Slips 13 as Stock Tests Key Support at 217 Allarity Therapeutics ALLR Hovers Near Support as Mild Pullback Tests Key Levels Alerus Financial ALRS Sees Modest Decline Amidst Broader Financial Sector Pressures US Military Drill in Venezuela Signals Geopolitical Risk Amid Political Transition SCM Q1 2026 Earnings Slight EPS Miss Amid Stable Portfolio Performance Clearwater Paper CLW Surges 689 Key Technical Levels and Market Drivers Behind the Move Deere Q1 2026 Earnings Strong EPS Beat Amidst Weak Agricultural Demand Star Bulk Carriers Q1 2026 Earnings EPS Beats Estimates by 24 Shares Dip Despite Strong Results PCT Q1 2026 Earnings Narrowerthanexpected loss amid continued polypropylene recycling progress PURR Q1 2026 Earnings Strong EPS Beat Overshadowed by Revenue Uncertainty Meritage Homes MTH Q1 2026 Earnings EPS Misses Estimates Despite Solid Demand PRTC Q4 2024 Earnings EPS Misses Estimates as Pipeline Progress Continues PDSB Q1 2026 Earnings Narrower Loss Surpasses Expectations as Clinical Progress Continues